Home | Terms of Use | Privacy Statement | Contact Us For U.S. healthcare professionals only.
		About Kepivance® (palifermin)   Video Watch a Biological  Video online...   Description Explanation of the unique characteristics of Kepivance®. Mechanism of Action Information about the effect of Kepivance® on the phases of oral mucositis. Pharmacokinetics How Kepivance® is absorbed, distributed, metabolized, and eliminated by the body. Efficacy Facts and figures regarding the effectiveness of Kepivance® for managing severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support (HSCT). Safety & Tolerability Important information concerning adverse events. Dosing Specific information about the administration of Kepivance®. Preparation and Storage Details regarding the distribution and proper storage of Kepivance®. Frequently Asked Questions Answers to common questions about Kepivance®. ABOUT ORAL MUCOSITIS ABOUT KEPIVANCE® TOOLS AND RESOURCES FOR NURSES FOR PHARMACISTS IMPORTANT PRODUCT SAFETY INFORMATION
	Kepivance® is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support. The safety and efficacy of Kepivance® have not been established in patients with non-hematologic malignancies. Important Safety Information In patients with hematologic malignancies, the most common serious adverse reaction in clinical trials attributed to Kepivance® was skin rash reported in less than 1% of patients.   Contact | Reimbursement | Biovitrum.com | Site Map Prescribing Information © 2008 Biovitrum AB (publ). All rights reserved.